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This study demonstrates that the Inhibition of adenylate cyclase activity by Ca” is enhanced m the presence of mcreasmg [EGTA] (0, 0.3. 1. 2.5 
mM) by 2 orders of magnitude. It has been established that this effect is not because of poor Ca” buffering by low [EGTA] or high Ca*’ bmdmg 
by the membrane preparation. It is present irrespective of stimulus. We suggest the enhanced sensitivity of adenylate cyclase to Ca” induced by 
EGTA is caused by the Ca-EGTA complex being a more Inhibitory spectes than Ca”. Thus consideration of the effects of the CapEGTA complex 
should be made when interpreting the results from expertments mvolving Ca” and EGTA. 
Adenylate cyclase: Calctum; EGTA; Human duodenum 
1. INTRODUCTION 
The regulation of fluid and electrolyte flux by cyclic 
AMP and Ca” is the paradigm of second messenger 
function in the small intestine. The relationship between 
intracellular cyclic AMP and Cal+, however. remains 
obscure in this tissue. In other tissues (e.g. brain) Ca” 
and calmodulin (a Ca”-binding protein) are known to 
regulate adenylate cyclase activity [l]. A number of in- 
vestigators have demonstrated that Ca” inhibits the 
activity of adenylate cyclase at concentrations higher 
than 1 PM while at submicromolar Ca’+ concentrations 
activation of the enzyme occurs [l-8]. It is thought that 
this activation of adenylate cyclase activity is mediated 
by calmodulin but the inhibition of the enzyme by Ca’+ 
is calmodulin-independent [9]. 
The use of the Ca”-chelating agent EGTA, is an 
established method for the in vitro control of free cal- 
cium concentrations in enzyme assay systems [ 10-141. 
Contamination of buffered solutions by Ca’+ (in some 
cases up to 20 PM) necessitates the use of buffers con- 
taining EGTA to control and estimate free [Ca”] 
[11,14]. EGTA is also used to deplete membrane prepa- 
rations of calcium and/or calmodulin [ 1,2.4.15-l 81. The 
concentration at which EGTA is used varies considera- 
bly from micromolar [ 19-241 through to millimolar con- 
centrations [2,8,13,16,25-271. The inhibition of adenyl- 
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2.1. The effects of culeiun~ and EGTA on adeqkte eyclase actn’ii~ 
The Ca” concentratron response of adenylate cyclase activity in 
biopsy parttculate membranes was conducted with dtfferent control- 
ling [EGTA]. For each calcium chloride addttion, the free [Ca”] was 
computed using an nerative hgand-metal bindmg programme 
[34.37,38]. Stock [Cal’] were checked with a calcium-sensttive elec- 
trode and the pH of the buffers dtd not vary over the [Ca’+] range 
studied [16]. 
Ahbreviutmw GMP-PNP. Y-guanylyl-imtdodiphosphate; Fura-2. To further mvesttgate the effects of EGTA on Ca” inhtbition of 
1(2(5-carboxyoxozol-2-yl)-6-ammobenzo-furan-5-oxy)-3-(2’-am~no- adenylate cyclase activity, the concentration dependence of adenylate 
5’-methylphenoxyl)-ethane-N.N.N’.N-tetraacetic acid. cyclase activity to EGTA m the absence and in the presence of (1 PM) 
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ate cyclase activity by EGTA has been taken as an 
indication that the enzyme has a calmodulin-sensitive 
component and thus a requirement for Ca”. The effec- 
tive [EGTA] that inhibits adenylate cyclase activity is 
also subject to variability depending on the source of the 
tissue under study [10,19,21,28-331. 
Previously we have reported the nature of human 
duodenal adenylate cyclase activity to be calmodulin- 
insensitive and inhibited by submicromolar free [Ca”] 
[34]. During that study it was observed that the concen- 
tration of free Ca” that inhibited adenylate cyclase ac- 
tivity decreased as controlling [EGTA] increased. This 
suggests that the presence of EGTA in the assay systems 
increases the sensitivity of the enzyme to Ca’+. In this 
study we have examined this phenomenon and estab- 
lished that the Ca-EGTA complex is a more inhibitory 
species than Ca’+ to adenylate cyclase activity. 
2. MATERIALS AND METHODS 
Btopstes from the second part of the human duodenum were col- 
lected and prepared as described previously [34]. Adenylate cyclase 
activtty was assayed in the membranes by the method of Salomon [35] 
as previously described [34]. Incubations were conducted in the pres- 
ence of 30 pg membrane protein for 30 min at 37°C. pH 7 [36]. 
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free calcmm was measured under basal and various stimulatmg condi- 
tions. 
3 ’ CU/CW~Z contanmutwn und calctunt-boding cupcity oj wwm- -.-. 
brunrs 
The concentrations of contaminatmg Ca” m the buffer solutions 
and the Ca”-bmding capacity of the biopsy particulate membrane 
preparation were estimated using the Ca” fluorescence indicator 
Fura- [39,40]. The contaminating free [Ca’+] was estimated in the 
Mg”/HEPES tissue buffer and in a bulk volume of the adenylate 
cyclase reaction mixture. Excitation scans of 2 ml of 5 mM Mg”/? mM 
HEPES or adenylate cyclase reaction mlwture [34] contammg 5 PM 
Fura- were performed m 1 cm light path, 4 ml fluorlmetrlc cuvettes 
in a Kontron SFM 25 spectrofluorimeter at 37°C. The emlsslon wave- 
length was set at 505 nm. A standard curve of Ca” concentration 
against peak excitation wavelength was established using Mg’+/ 
HEPES tissue buffer containing 0.3 mM EGTA and CaCl, to give 
calculated free [Ca”] ranging from 0.00788 PM to 104.5 PM. From 
the curve the Ca” contamination m the Mg”/HEPES buffer was 
estimated to be 1.4 PM and in the adenylate cyclase reaction rmxture 
tobe25yM. 
The Ca”-bmdmg capacity of the biopsy particulate membrane 
preparations was estimated usmg this system and compared to that of 
EGTA. Six membrane preparations were each resuspended in 2 ml 
Mg”/HEPES buffer contaming 5 PM Fura- (about 2 mg/ml mem- 
brane protein) and excltatlon-scanned as described above. For com- 
parison 2 ml Mg”/HEPES buffer containing 0.3 mM EGTA was also 
excitation scanned. 
Ethical permIssIon for the study was obtained from the Nottingham 
City Hospital Ethical Committee and patients gave Informed written 
consent. 
3. RESULTS AND DISCUSSION 
3.1. The effect of calcium and EGTA on udenylute 
cyclase activit? 
The mean Ca’+ concentration at which adenylate 
A B 
Basal 
Table I 
Inhibition (50%) of human duodenal adenylate cyclase actlvq b) 
Ca” m the presence of increasing controlling EGTA concentrations 
[EGTA] 
(mM) 
0.0 
0.3 
1.0 
25 
ICs,, for IC,, for NaF (IO mM ) 
basal actlvlty stimulated actikitl 
WM) luM) 
51.32 * 15.77 62.82 * 3 76 
42.19 f 10.59 3105 f 0 57 
1.50 f 0.14 2.99 f 0.70 
0.19 rt 0.06 0.19 * 0 04 
cyclase activity was inhibited by 50% (I&,) was de- 
duced from three Ca’+-response curves obtained in the 
presence of 0, 0.3, 1 .O and 2.5 mM EGTA (Table I). The 
results show that the concentration of free Ca” that 
inhibited adenylate cyclase activity in biopsy particulate 
membranes decreased as the [EGTA] was increased, i.e. 
EGTA shifts the adenylate cyclase concentration re- 
sponse to free Ca” to the left (left shift). The left shift 
was observed for both basal and NaF stimulated 
adenylate cyclase activity. 
3.2. Membwnr calcium binding 
It has been postulated that high Ca” binding capac- 
ity of membrane preparations in the presence of low 
[EGTA] may account for the left shift, i.e. high [EGTA] 
are necessary to effectively buffer free Ca’+ [3,13]. This 
may have particular relevance to duodenal membranes 
which have a significant physiological role in the uptake 
of Ca”+ from the gut lumen. The hypothesis was tested 
in duodenal biopsy membrane preparations using the 
C 
GMP-PNP 1 
01 oJ-----d 
0.5 1.0 1.5 2.0 2.5 0.5 1.0 1.5 2.0 2.5 
[EGTA] mM 
Fig. 1. The response of adenylate cyclase activity to increasmg EGTA concentrations m the presence of no added CaClz (0) and 1 PM free Ca” 
(w). Basal (A). 50 PM forskohn (B) and 1 PM GMP-PNP (C) stimulated activities are shown in particulate membranes from human duodenal 
biopsies Membranes were washed in buffer (4°C) contammg 5 mM EGTA. 5 mM Mg’+ and 2 mM HEPES to remove any bound Ca” prior to 
adenylate cyclase assay. Data are the mean of at least 3 separate membrane preparations. assayed m triphcate. 
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Fig. 2. Shows a range of IC,, values and EGTA concentrations ob- 
tamed from published results (m). Each point is referenced. The IC,,, 
data from Table I are superimposed for comparison (0). The different 
tissues used are as follows: 3, guinea-pig brain and heart ventricles; 5*. 
NCB-20 cells (biphaslc response); 10, dog heart sarcolemma; 18*, 
gumea-pig enterocyte membranes: 21*, crayfish muscle; 25, luteal 
cells: 27. bovine aorta smooth muscle mlcrosomes; 34. human duode- 
nal membranes; 41* and 42, turkey erythrocyte membranes; 43, 
Drwophilu wild-type heads and abdomens, rutabaga heads; 44*, rat 
cerebellum: 45. moth brain: 46, dog parathyroid; 47*. rabbit heart 
plasma membranes. * indicates I&, values estimated from a graph or 
table. 
fluorescent indicator Fura-2. Duodenal biopsy mem- 
branes added to Mg2+/HEPES tissue buffer containing 
Fura- (in which the contaminating Ca” concentration 
was approximately 1.4 PM), caused a shift in the peak 
excitation spectra to the right (i.e. longer wavelength, 
mean 332.67 nm + 0.81 S.D., n = 6) equivalent to a free 
Ca2+ concentration of 0.7 ,LLM. EGTA (0.3 mM), on the 
other hand, caused a shift in the peak excitation spectra 
equivalent to a reduction in the free [Ca”] to 0.003 ,uM 
(excitation peak = 344 nm, n = 3). Therefore, the Ca”- 
binding capacity of the membranes was negligible com- 
pared to that of EGTA. The increased sensitivity of 
adenylate cyclase to Ca2’ in the presence of EGTA, 
cannot therefore be explained by inadequate buffering 
by low [EGTA]. 
3.3. Ca-EGTA complex 
The left shift effect may be explained by considering 
the Ca-EGTA complex as a more active inhibitory spe- 
cies than Ca2’. To test this hypothesis [EGTA] re- 
sponses were conducted with and without a fixed con- 
centration of free Ca*’ under differing stimulating con- 
ditions (Fig. lA-C). 
In the presence of a maintained free [Ca’+] (1 PM), 
adenylate cyclase activity was inhibited by EGTA, 
whereas in the absence of a maintained [Ca”], EGTA 
stimulated enzyme activity. This supports the idea that, 
in these experiments, the Ca-EGTA complex was the 
more inhibitory species and not EGTA or Ca” per se. 
When the [Ca’+] was maintained at 1 ,LLM, CaCl, and 
EGTA were added at almost equimolar concentrations 
(Ca”/EGTA, respectively: 0.246 mM: 0.3 mM; 0.824 
mM: 1 mM; 2.049 mM: 2.5 mM). Therefore the concen- 
tration of the Ca-EGTA complex increased as the 
[EGTA] increased. In the absence of added Ca’+ (i.e. 
when EGTA stimulated enzyme activity and the ratio 
of Ca’+ to EGTA was very small), EGTA was freely 
available to chelate the contaminating Ca’+ in solution 
(2.5 ,LLM) and the [Ca-EGTA] remained low as the 
[EGTA] was increased. In the absence of added Ca’+, 
EGTA did not inhibit adenylate cyclase activity at any 
[EGTA] tested. Under these conditions EGTA may 
have been available to chelate membrane-bound Ca’+ 
resulting in apparent enzyme stimulation. This suggests 
that human duodenal adenylate cyclase activity may be 
regulated by Ca” directly and not via calmodulin [5]. 
The effects of Ca-EGTA on adenylate cyclase activ- 
ity were similar irrespective of which component of the 
adenylate cyclase system was stimulated (i.e. forskolin 
stimulated catalytic unit or GMP-PNP stimulated G 
proteins). It is therefore conceivable that the mechanism 
involves interaction between Ca-EGTA and the cata- 
lytic unit of the enzyme. Interaction of EGTA with a 
hydrophobic region of particulate adenylate cyclase 
from rat cerebral cortex has been previously demon- 
strated. However, it was unknown whether this hydro- 
phobic region represents membrane associated calmod- 
ulin or the catalytic unit [29,30]. Our data, using duode- 
nal particulate membranes, suggests Ca-EGTA inter- 
acts with the catalytic unit of adenylate cyclase. 
Fig. 2 is a survey of published IC,, values for the 
inhibition of adenylate cyclase activity by Ca7+ and the 
corresponding [EGTA] used by other workers to con- 
trol free Ca2’ in assay media. Despite the widely differ- 
ing tissues and assay conditions employed, Fig. 2 high- 
lights the left shift observed in this study. In the absence 
of EGTA, Ca2+ apparently does not inhibit adenylate 
cyclase activity at physiologically relevant intracellular 
concentrations (at resting < 1 ,uM, stimulated 1-2 ,uM 
[3,91X 
Finally both this data and that shown in Fig. 2 indi- 
cates that in some tissues it is difficult to draw firm 
conclusions about specific mechanisms for Ca’+ regula- 
tion of adenylate cyclase activity because of the interfer- 
ing effects of the Ca-EGTA complex (effects that are 
obviously not present in vivo). Thus careful considera- 
tion of the effects of Ca-EGTA should be made when 
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interpreting the results from experiments involving Ca’+ 
and EGTA. 
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